Surface Antigens/Receptors for Targeted Cancer Treatment: The GnRH Receptor / Binding Site for Targeted Adenocarcinoma Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|4|8|673-687

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.4, Iss.8, 2004-01, pp. : 673-687

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gonadotropin-Releasing Hormone (GnRH) Receptors in Tumors: a New Rationale for the Therapeutical Application of GnRH Analogs in Cancer Patients?

By  

Current Cancer Drug Targets, Vol. 6, Iss. 3, 2006-05 ,pp. : 257-269

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Cancer Therapy: The Next Generation of Cancer Treatment

By  

Current Drug Discovery Technologies, Vol. 12, Iss. 1, 2015-01 ,pp. : 3-20

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenomics Opportunities in Nuclear Receptor Targeted Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 2, Iss. 3, 2002-01 ,pp. : 243-256

Bentham Science Publishers

Access to resources Recommend Favorite

Somatostatin Receptor-Targeted Anti-Cancer Therapy

By  

Current Drug Delivery, Vol. 8, Iss. 1, 2011-01 ,pp. : 2-10

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted therapy of hepatocellular cancer

By Wysocki Piotr Jan  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 2, 2010-02 ,pp. : 265-274

Informa Healthcare

Access to resources Recommend Favorite